Enspectra Health
About Enspectra Health
Enspectra Health is at the forefront of digital dermatology, pioneering the field of virtual biopsies with its innovative VIO™ Skin Platform. This FDA-cleared, handheld, cross-modal imaging technology is designed to transform how physicians evaluate a broad spectrum of skin conditions. The VIO System integrates reflectance confocal microscopy with multiphoton laser scanning microscopy to generate real-time, high-resolution, multispectral images of cellular structures in living skin, eliminating the need for an incision.
This technology provides immediate digital pathology insights, allowing dermatologists and pathologists with skin histology training to visualize various tissue features, including blood vessels, collagen, pigment, stratum corneum, hair follicles, and cellular atypia, to assist in forming a clinical judgment. The primary goal is to minimize unnecessary traditional biopsies, facilitate earlier disease diagnosis, and streamline the evaluation of skin conditions, particularly non-melanoma skin cancers like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
Enspectra Health further leverages artificial intelligence and machine learning to develop advanced applications from its imaging data. Notably, its VIO.ai NMSC software function recently received FDA Breakthrough Device Designation for lesion classification, providing computer-aided diagnosis and triage (CADx/CADt) to support physicians in clinical decision-making for suspicious BCC and SCC in high-risk populations. The company aims to digitize the entire dermatological evaluation process, extending its platform’s utility to general skin health assessment, photoaging, and evaluating the efficacy of topical drugs for various dermatological conditions.
Focus Areas
Business Intelligence
| Key Investors | Tsingyuan Ventures, Foothill Ventures, Joyance Partners, National Cancer Institute (NIH) |
| Partnerships | Golden State Dermatology, Fogarty Innovation |
| Technology | VIO System, combines reflectance confocal microscopy and multiphoton microscopy, handheld device, AI-powered VIO™ Skin Platform (VIO) with VIO.ai NMSC (Computer-Aided Diagnosis and Triage software) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Enspectra Health's technology offers a paradigm shift in dermatological diagnostics. Consider integrating this for patients who are anxious about traditional biopsies, those with lesions in cosmetically sensitive areas, or for rapid initial assessment to streamline your workflow. The AI-powered decision support can act as a valuable second opinion, enhancing diagnostic confidence and potentially reducing unnecessary excisions. Emphasize the non-invasive nature and speed of results to patients to improve their experience and compliance.
Enspectra Health's platform is designed with potential for seamless integration into existing clinical workflows. This includes compatibility with Electronic Health Record (EHR) systems for streamlined patient data management, Picture Archiving and Communication Systems (PACS) for image storage and retrieval, and potentially telemedicine platforms for remote consultations and second opinions, enhancing interoperability within a modern dermatology practice.
Reviews & Opinions
Videos
News, demos, and interviews about Enspectra Health.
Videos load interactively. If none appear, search YouTube for Enspectra Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Enspectra Health.
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]